(Q34059164)

30 July 2017

1 reference

title

Helicobacter pylori gastritis and gastric physiology (English)

1 reference

Helicobacter pylori gastritis

30 July 2017

0 references

0 references

1 reference

McColl KE

1

1 reference

30 July 2017

el-Omar E

series ordinal

2

1 reference

30 July 2017

Gillen D

series ordinal

3

1 reference

30 July 2017

language of work or name

1 reference

1 September 2000

1 reference

Gastroenterology Clinics of North America

30 July 2017

1 reference

30 July 2017

29

1 reference

30 July 2017

3

1 reference

30 July 2017

687-703, viii

1 reference

Antral gastrin-producing G-cells and somatostatin-producing D-cells in different states of gastric acid secretion

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Is Helicobacter pylori associated hypergastrinaemia due to the bacterium's urease activity or the antral gastritis?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Helicobacter pylori infection and chronic gastric acid hyposecretion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Effects of aging and gastritis on gastric acid and pepsin secretion in humans: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Helicobacter pylori infection and exaggerated gastrin release. Effects of inflammation and progastrin processing.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Eradication of Helicobacter pylori in patients with duodenal ulcer lowers basal and peak acid outputs to gastrin releasing peptide and pentagastrin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Somatostatin is an essential paracrine link in acid inhibition of gastrin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Effect of omeprazole on duodenal ulcer-associated antral gastritis andHelicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Effect of intragastric pH on antral gastrin and somatostatin release in anaesthetised, atropinised duodenal ulcer patients and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Helicobacter pylori infection induces a decrease in immunoreactive-somatostatin concentrations of human stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Influence of chronic drug-induced achlorhydria by substituted benzimidazoles on the endocrine stomach in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Review article: the development of atrophic gastritis--Helicobacter pylori and the effects of acid suppressive therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Time-course of development and reversal of gastric endocrine cell hyperplasia after inhibition of acid secretion. Studies with omeprazole and ranitidine in intact and antrectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Somatostatin Cell Processes as Pathways for Paracrine Secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Campylobacter pylori and duodenal ulcers: the gastrin link

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Antral Helicobacter pylori, hypergastrinaemia, and duodenal ulcers: effect of eradicating the organism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

High basal gastric acid secretion in somatostatin receptor subtype 2 knockout mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Plasma Gastrin, Daytime Intragastric pH, and Nocturnal Acid Output before and at 1 and 7 Months after Eradication ofHelicobacter pyloriin Duodenal Ulcer Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Lowered gastrin and gastric acidity after eradication of Campylobacter pylori in duodenal ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Gastrin induces heparin-binding epidermal growth factor-like growth factor in rat gastric epithelial cells transfected with gastrin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

The gastric enterochromaffin-like cell: an enigmatic cellular link

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Helicobacter pylori related hypergastrinaemia is the result of a selective increase in gastrin 17

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Enterochromaffin-like cells in rat stomach respond to short-term infusion of high doses of cholecystokinin but not to long-term, sustained, moderate hyperCCKemia caused by continuous cholecystokinin infusion or pancreaticobiliary diversion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Amoxycillin plus tinidazole for Campylobacter pylori gastritis in children: assessment by serum IgG antibody, pepsinogen I, and gastrin levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Effect of Helicobacter pylori eradication on antral gastrin- and somatostatin-immunoreactive cell density and gastrin and somatostatin concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Treatment with proton pump inhibitors induces tolerance to histamine-2 receptor antagonists in Helicobacter pylori-negative patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Differing patterns of Helicobacter pylori gastritis in patients with duodenal, prepyloric, and gastric ulcer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Asymptomatic H. pylori infection impairs pH inhibition of gastrin and acid secretion during second hour of peptone meal stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

pH dependence of acid secretion and gastrin release in normal and ulcer subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Histopathology of gastroduodenal inflammation: the impact of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

Somatostatin receptor subtype 2 mediates inhibition of gastrin and histamine secretion from human, dog, and rat antrum

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970138-2

7 January 2021

10.1016/S0889-8553(05)70138-2

Identifiers

DOI

1 reference

30 July 2017

1 reference